Cutter Capital Management, LP Gilead Sciences, Inc. Transaction History
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
A detailed history of Cutter Capital Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 292,959 shares of GILD stock, worth $27.6 Million. This represents 6.07% of its overall portfolio holdings.
Number of Shares
292,959
Previous 265,436
10.37%
Holding current value
$27.6 Million
Previous $19.4 Billion
3.38%
% of portfolio
6.07%
Previous 7.43%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,913Shares Held
1.02BCall Options Held
11.9MPut Options Held
8.95M-
Black Rock Inc. New York, NY121MShares$11.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.9 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$7.19 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.7 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.6 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $118B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...